Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company
10 July 2024 - 3:00PM
Terumo Blood and Cell Technologies (Terumo BCT), a Colorado-based
global leader in medical technology, celebrates 60 years of
partnerships across the Front Range. Balancing global investment
with local commitment, the Lakewood-based company actively invests
in its future and community.
Building on its blood banking legacy, the company is expanding
into plasma-derived therapies, clinical therapeutics, and cell and
gene therapy technologies. If you have ever donated blood or know
somebody who has received a blood transfusion or stem cell
transplant, Terumo BCT’s products were likely used during the
procedure.
Terumo BCT connects its priorities to the patients it serves. It
is committed to helping set healthcare standards by funding an
innovation pipeline that supports expanded treatment options for
conditions including sickle cell disease, blood cancers and rare
diseases. For over 100 years, Japan-based Terumo Group has been a
strong, stable force in healthcare, investing for the long term.
The local operations have proudly been part of the Terumo legacy
since 2011. At its Lakewood and Littleton facilities, the company
hires a diverse range of talented individuals across various
disciplines. Its calling is clear: to get innovative medical
technology into the hands of patients who need it most. Some of
Terumo BCT’s contributions include:
- Economic growth: Demonstrating commitment to Colorado,
employing about 2,000 people and increasing its workforce in
Jefferson and Douglas counties. Invested $250 million in a
state-of-the-art manufacturing plant in Douglas County that opened
in 2022.
- Colorado partnerships: Collaborating with groups such as
the Colorado Bioscience Association and working with local
innovators on promising new treatments, including Fort
Collins-based Photon Pharma, a Colorado State University (CSU)
start-up, working on a clinical trial exploring a novel ovarian
cancer treatment.
- Education: Supporting local education programs for
science, technology, engineering and mathematics (STEM) for 20
years. Its partnership with STEMblazers offers hands-on experiences
to inspire interest in STEM fields and healthcare, especially among
teen girls in the Denver-metro area. Terumo BCT also works to grow
its talent with a robust internship program including students from
CSU, University of Colorado and Colorado School of Mines.
- Responsible corporate citizen: Engaging with the
communities it serves. Locally, the company supports Lakewood’s The
Action Center, which addresses financial hardship and food
insecurity. And, through tireless dedication, employees have raised
about $2 million for the local Leukemia & Lymphoma Society
chapter.
- Leadership in blood donations: Playing a prominent
ongoing role in encouraging Coloradans to donate blood to replenish
the greatly needed supplies. Learn more about our commitment to
this at TerumoBCT.com/DropofHope.
“We think globally and act locally. This has been our approach
for 60 years and will continue to guide us,” said Antoinette Gawin,
President and Chief Executive Officer at Terumo BCT. “Impact starts
at home. Our strong foundation in Colorado allows us to serve
patients, extend care outward and make a difference globally.”
About Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies is a medical technology
company. Our products, software and services enable customers to
collect and prepare blood and cells to treat
challenging diseases and conditions. Our employees worldwide
believe in the potential of blood and cells to do even more
for patients than they do today. This belief inspires our
innovation and strengthens our collaboration with
customers.
Terumo Blood and Cell Technologies' customers include blood
centers, hospitals, therapeutic apheresis clinics, cell
collection and processing organizations, researchers and private
medical practices. Our customers are based in over 150
countries across the globe. We have 750+ granted patents, with
more than 150 additionally pending.
We have global headquarters in Lakewood, Colorado, U.S.A., along
with five regional headquarters, seven manufacturing sites and
six innovation and development centers across the globe.
Terumo Blood and Cell Technologies is a subsidiary of Terumo
Corporation (TSE:4543), a global leader in medical technology.
- Drop of Hope
- Terumo BCT celebrates 60 years
Christine Romero
Terumo Blood and Cell Technologies
press@terumobct.com